• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The potential indicators for pulmonary fibrosis in survivors of severe COVID-19.

作者信息

Huang Wenhui, Wu Qingxia, Chen Zhuozhi, Xiong Zhiyuan, Wang Kun, Tian Jie, Zhang Shuixing

机构信息

College of Medicine and Biological Information Engineering, Northeastern University, Liaoning, China; Department of Radiology, The First Affiliated Hospital, Jinan University, Guangdong, China.

College of Medicine and Biological Information Engineering, Northeastern University, Liaoning, China.

出版信息

J Infect. 2021 Feb;82(2):e5-e7. doi: 10.1016/j.jinf.2020.09.027. Epub 2020 Sep 28.

DOI:10.1016/j.jinf.2020.09.027
PMID:32998036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7521372/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb4/7521372/75385962d273/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb4/7521372/75385962d273/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fb4/7521372/75385962d273/gr1_lrg.jpg

相似文献

1
The potential indicators for pulmonary fibrosis in survivors of severe COVID-19.重症 COVID-19 幸存者中肺纤维化的潜在指标。
J Infect. 2021 Feb;82(2):e5-e7. doi: 10.1016/j.jinf.2020.09.027. Epub 2020 Sep 28.
2
Pulmonary fibrosis and follow-up of COVID-19 survivors: an urgent need for clarification.新冠肺炎康复者的肺纤维化及随访：亟待澄清
J Bras Pneumol. 2021 Sep 6;47(4):e20210213. doi: 10.36416/1806-3756/e20210213.
3
[Research advances in the mechanism of pulmonary fibrosis induced by coronavirus disease 2019 and the corresponding therapeutic measures].[2019冠状病毒病所致肺纤维化机制及相应治疗措施的研究进展]
Zhonghua Shao Shang Za Zhi. 2020 Aug 20;36(8):691-697. doi: 10.3760/cma.j.cn501120-20200307-00132.
4
Pulmonary Fibrosis Due to COVID-19 Pneumonia.新型冠状病毒肺炎所致肺纤维化
Korean J Radiol. 2020 Nov;21(11):1273-1275. doi: 10.3348/kjr.2020.0707. Epub 2020 Jul 17.
5
Pulmonary fibrosis secondary to COVID-19: a call to arms?新型冠状病毒肺炎继发的肺纤维化：吹响战斗的号角？
Lancet Respir Med. 2020 Aug;8(8):750-752. doi: 10.1016/S2213-2600(20)30222-8. Epub 2020 May 15.
6
Three-month Follow-up Study of Survivors of Coronavirus Disease 2019 after Discharge.新冠肺炎出院患者 3 个月随访研究。
J Korean Med Sci. 2020 Dec 7;35(47):e418. doi: 10.3346/jkms.2020.35.e418.
7
Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19.COVID-19 患者自主呼吸时快速进展的蜂窝状纤维化。
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.01808-2020. Print 2020 Aug.
8
Novel insight from the first lung transplant of a COVID-19 patient.首例 COVID-19 患者肺移植的新见解。
Eur J Clin Invest. 2021 Jan;51(1):e13443. doi: 10.1111/eci.13443. Epub 2020 Nov 20.
9
Characteristics of mortal COVID-19 cases compared to the survivors.与幸存者相比，COVID-19 死亡病例的特征。
Aging (Albany NY). 2020 Nov 21;12(24):24579-24595. doi: 10.18632/aging.202216.
10
Prediction of the Development of Pulmonary Fibrosis Using Serial Thin-Section CT and Clinical Features in Patients Discharged after Treatment for COVID-19 Pneumonia.利用 COVID-19 肺炎治疗后出院患者的系列薄层 CT 和临床特征预测肺纤维化的发展。
Korean J Radiol. 2020 Jun;21(6):746-755. doi: 10.3348/kjr.2020.0215.

引用本文的文献

1
Diabetes mellitus increases the risk of post-COVID-19 pulmonary fibrosis: a meta-analysis of observational studies.糖尿病增加新冠病毒感染后肺纤维化的风险：一项观察性研究的荟萃分析
BMC Pulm Med. 2025 Aug 12;25(1):386. doi: 10.1186/s12890-025-03880-x.
2
The Role of Serum Prolidase Activity, MMP-1, MMP-7, and TGF-β Values in the Prediction of Early Fibrosis in Patients with Moderate to Severe COVID-19.血清脯氨酰肽酶活性、基质金属蛋白酶-1、基质金属蛋白酶-7和转化生长因子-β值在中重度新型冠状病毒肺炎患者早期纤维化预测中的作用
Viruses. 2025 Jul 6;17(7):954. doi: 10.3390/v17070954.
3
Retrospective cohort analysis on predicting pulmonary fibrosis in elderly SARS-CoV-2-infected patients.

本文引用的文献

1
Respiratory follow-up of patients with COVID-19 pneumonia.COVID-19 肺炎患者的呼吸随访。
Thorax. 2020 Nov;75(11):1009-1016. doi: 10.1136/thoraxjnl-2020-215314. Epub 2020 Aug 24.
2
Pulmonary fibrosis in the aftermath of the COVID-19 era (Review).新冠疫情时代后的肺纤维化（综述）
Exp Ther Med. 2020 Sep;20(3):2557-2560. doi: 10.3892/etm.2020.8980. Epub 2020 Jul 9.
3
Rapid onset honeycombing fibrosis in spontaneously breathing patient with COVID-19.COVID-19 患者自主呼吸时快速进展的蜂窝状纤维化。
对老年新型冠状病毒肺炎感染患者肺纤维化预测的回顾性队列分析
Front Cell Infect Microbiol. 2025 Jun 6;15:1587321. doi: 10.3389/fcimb.2025.1587321. eCollection 2025.
4
Transcriptomic profiling reveals the dynamics of fibrotic progression-related gene expression into post-coronavirus disease 2019 pulmonary fibrosis.转录组分析揭示了2019冠状病毒病后肺纤维化中纤维化进展相关基因表达的动态变化。
Clin Transl Med. 2024 Nov;14(11):e70088. doi: 10.1002/ctm2.70088.
5
Pulmonary fibrosis followed by severe pneumonia in patients with COVID-19 infection requiring mechanical ventilation: a prospective multicentre study.COVID-19 感染患者机械通气后出现肺纤维化伴严重肺炎：一项前瞻性多中心研究。
BMJ Open Respir Res. 2024 Oct 4;11(1):e002538. doi: 10.1136/bmjresp-2024-002538.
6
The Role of Cytokines and Molecular Pathways in Lung Fibrosis Following SARS-CoV-2 Infection: A Physiopathologic (Re)view.细胞因子和分子通路在SARS-CoV-2感染后肺纤维化中的作用：生理病理学（再）综述
Biomedicines. 2024 Mar 13;12(3):639. doi: 10.3390/biomedicines12030639.
7
A narrative review on tofacitinib: The properties, function, and usefulness to treat coronavirus disease 2019.托法替布的叙述性综述：其特性、功能及对治疗2019冠状病毒病的效用
Int J Crit Illn Inj Sci. 2023 Oct-Dec;13(4):192-198. doi: 10.4103/ijciis.ijciis_27_23. Epub 2023 Dec 26.
8
Long COVID-19 Pathophysiology: What Do We Know So Far?新冠长期症状的病理生理学：我们目前了解多少？
Microorganisms. 2023 Sep 30;11(10):2458. doi: 10.3390/microorganisms11102458.
9
Pharmacological approaches to pulmonary fibrosis following COVID-19.新冠病毒感染后肺纤维化的药理学治疗方法。
Front Pharmacol. 2023 Jun 15;14:1143158. doi: 10.3389/fphar.2023.1143158. eCollection 2023.
10
Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis.与特发性肺纤维化相比，新型冠状病毒肺炎后肺纤维化的临床病理概述
Biomedicines. 2023 Jun 17;11(6):1739. doi: 10.3390/biomedicines11061739.
Eur Respir J. 2020 Aug 27;56(2). doi: 10.1183/13993003.01808-2020. Print 2020 Aug.
4
Radiology-Pathology Correlation Demonstrating Organizing Pneumonia in a Patient Who Recovered from COVID-19.放射学与病理学相关性研究显示一名从新冠病毒疾病中康复的患者出现机化性肺炎。
Am J Respir Crit Care Med. 2020 Aug 15;202(4):598-599. doi: 10.1164/rccm.202004-1278IM.
5
COVID-19 and risk of pulmonary fibrosis: the importance of planning ahead.新型冠状病毒肺炎与肺纤维化风险：提前规划的重要性。
Eur J Prev Cardiol. 2020 Sep;27(13):1442-1446. doi: 10.1177/2047487320932695. Epub 2020 Jun 17.
6
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy.肺纤维化与 COVID-19：抗纤维化治疗的潜在作用。
Lancet Respir Med. 2020 Aug;8(8):807-815. doi: 10.1016/S2213-2600(20)30225-3. Epub 2020 May 15.
7
Abnormal pulmonary function in COVID-19 patients at time of hospital discharge.COVID-19 患者出院时的肺功能异常。
Eur Respir J. 2020 Jun 18;55(6). doi: 10.1183/13993003.01217-2020. Print 2020 Jun.
8
Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis.危重症和死亡 COVID-19 病例的风险因素：系统文献回顾和荟萃分析。
J Infect. 2020 Aug;81(2):e16-e25. doi: 10.1016/j.jinf.2020.04.021. Epub 2020 Apr 23.
9
Chest CT features are associated with poorer quality of life in acute lung injury survivors.胸部 CT 特征与急性肺损伤幸存者生活质量较差相关。
Crit Care Med. 2013 Feb;41(2):445-56. doi: 10.1097/CCM.0b013e31826a5062.